San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story and see what’s trending.
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/fbi?src=hash" target="_blank"gt;#fbilt;/agt;–The FBI has approved Verogen’s groundbreaking next-gen forensic DNA technology for upload to the National DNA Index Sys… […]
Conference call scheduled for 4:30 p.m. ET today- New Data from Phase 2 Study of VK2809 Presented at EASL 2019; Results Demonstrate Robust Efficacy at Doses as Low as 5 mg Daily- Phase 2b Study of VK2809 in Biopsy-Confirmed NASH Expected to Commence in… […]
A new venture capital firm, which in November marked its launch by raising a $53 million-plus fund to invest in startups, has made its first investment. Blueprint Equity managing partners Sheldon Lewis and Bobby Ocampo, 30-somethings who are part of a … […]
SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces completion of enrollment of the Company’s Phase 1 clinical trial of its internal Captisol-enabled (CE) Iohexol program. The CE-Iohexol program is designed to devel… […]
Months after consummating its hefty $62 billion deal to buy Ireland’s Shire, Japanese drugmaker Takeda is strengthening its roots in the United States and enriching its global research heft, by unveiling a 165,000-square-foot facility in San Diego, Cal… […]
Reports + Research Takeda Opens New Global Research Center in San Diego According to Xconomy, Takeda, a Japanese pharma, first North American acquisition was a San Diego biotech. Since that deal 14 years ago, Takeda has now established an impressive 16… […]
SAN DIEGO, May 1, 2019 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results fo… […]